Amplify Weight Loss Drug & Treatment ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell THNR and other ETFs, options, and stocks.

About THNR

THNR tracks a modified market cap-weighted index of companies from developed markets that manufacture and enable GLP-1 agonist pharmaceutical businesses. 

Index-Tracked
VettaFi Weight Loss Drug & Treat TR USD
Index-TrackedVettaFi Weight Loss Drug & Treat TR USD
Category
Health
CategoryHealth
Number of holdings
28
Number of holdings28
Inception Date
May 20, 2024
Inception DateMay 20, 2024

What's in this fund

Sectors

As of June 3, 2025
Healthcare88.65%
Consumer Defensive6.47%
Basic Materials4.88%

Top 10 Holdings (70.76% of total assets)

As of June 4, 2025
NameSymbol% Assets
Eli LillyLLY13.98%
Novo NordiskNVO13.87%
Innovent Biologics Inc01801 (XHKG)7.41%
Hims & Hers HealthHIMS6.43%
Chugai Pharmaceutical Co Ltd4519 (XTKS)5.49%
Teva PharmaceuticalTEVA5.19%
AstraZenecaAZN4.66%
Roche Holding AGROG (XSWX)4.65%
West Pharmaceutical ServicesWST4.60%
AmgenAMGN4.48%

THNR Key Statistics

AUM
2.93M
AUM2.93M
Price-Earnings ratio
30.75
Price-Earnings ratio30.75
30-Day yield
1.08
30-Day yield1.08
Average volume
3.20K
Average volume3.20K
High today
$23.01
High today$23.01
Low today
$22.88
Low today$22.88
Open price
$22.95
Open price$22.95
Volume
1.12K
Volume1.12K
52 Week high
$28.19
52 Week high$28.19
52 Week low
$18.56
52 Week low$18.56
Expense ratio
0.59
Expense ratio0.59
View Prospectus and Reports

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted.